Celsius Holdings, Inc. (NASDAQ:CELH) Stock Holdings Decreased by Whittier Trust Co. of Nevada Inc.

Whittier Trust Co. of Nevada Inc. trimmed its position in Celsius Holdings, Inc. (NASDAQ:CELH) by 97.1% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 944 shares of the company’s stock after selling 31,249 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Celsius were worth $30,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Celsius by 18.7% in the 1st quarter. Vanguard Group Inc. now owns 16,313,762 shares of the company’s stock worth $1,352,737,000 after acquiring an additional 2,567,290 shares in the last quarter. Capital International Investors raised its holdings in shares of Celsius by 50.6% during the first quarter. Capital International Investors now owns 3,966,194 shares of the company’s stock worth $328,877,000 after purchasing an additional 1,333,217 shares during the period. Massachusetts Financial Services Co. MA lifted its position in shares of Celsius by 231.2% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock worth $225,289,000 after buying an additional 2,754,722 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Celsius by 36.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 2,942,433 shares of the company’s stock valued at $167,983,000 after buying an additional 790,014 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Celsius by 0.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,802,264 shares of the company’s stock valued at $232,365,000 after buying an additional 9,054 shares during the last quarter. 60.95% of the stock is owned by institutional investors.

Celsius Trading Up 4.1 %

NASDAQ:CELH opened at $31.70 on Friday. The company has a 50-day moving average of $34.11 and a 200-day moving average of $54.69. Celsius Holdings, Inc. has a twelve month low of $28.20 and a twelve month high of $99.62. The firm has a market cap of $7.39 billion, a price-to-earnings ratio of 34.84, a price-to-earnings-growth ratio of 2.29 and a beta of 1.84.

Celsius (NASDAQ:CELH) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.05. The firm had revenue of $402.00 million for the quarter, compared to analyst estimates of $391.07 million. Celsius had a net margin of 19.58% and a return on equity of 94.75%. The firm’s quarterly revenue was up 23.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.17 earnings per share. On average, research analysts forecast that Celsius Holdings, Inc. will post 0.82 earnings per share for the current year.

Insider Activity at Celsius

In other Celsius news, CEO John Fieldly sold 74,847 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $32.80, for a total transaction of $2,454,981.60. Following the sale, the chief executive officer now owns 1,812,490 shares in the company, valued at approximately $59,449,672. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.20% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of brokerages have commented on CELH. Truist Financial lifted their target price on Celsius from $30.00 to $35.00 and gave the company a “hold” rating in a research note on Wednesday, October 16th. Bank of America cut their target price on Celsius from $32.00 to $26.00 and set an “underperform” rating on the stock in a research note on Thursday, September 5th. Stifel Nicolaus dropped their price objective on shares of Celsius from $61.00 to $51.00 and set a “buy” rating on the stock in a report on Thursday, September 5th. Jefferies Financial Group reduced their target price on shares of Celsius from $53.00 to $48.00 and set a “buy” rating for the company in a research note on Thursday, October 10th. Finally, UBS Group dropped their price target on shares of Celsius from $70.00 to $64.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $58.00.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.